MAP2K7 and chondrosarcoma: In our current investigation, we discovered that visfatin stimulates the Raf/MEK/ERK pathway and activates HIF-1α as well as suppresses the expression of miR-2277-3p, thereby promoting VEGF-D-mediated lymphangiogenesis in chondrosarcoma.